20/20 Biolabs Inc. (AIDX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-03-10
5:18 pm
Purchase
2026-02-1913G20/20 Biolabs, Inc. Common Stock
AIDX
Full Succeed International Limited651,465
6.300%
651,465increase
(New Position)
Filing
History
2026-03-10
5:14 pm
Purchase
2026-03-0313D20/20 Biolabs, Inc. Common Stock
AIDX
Jonathan M Cohen1,833,750
16.800%
1,833,750increase
(New Position)
Filing
History
2026-02-25
3:10 pm
Purchase
2026-02-2513G20/20 Biolabs, Inc. Common Stock
AIDX
Streeterville Capital LLC543,680
9.900%
543,680increase
(New Position)
Filing
History